Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–2 of 2 stories
Soligenix reports positive Phase 2 results for SGX945 in treating Behçet's disease, indicating potential for significant market impact. The company also announced top-line results for SGX302 in mild-to-moderate psoriasis, highlighting its commitment to advancing rare disease therapies.
Read full storyA rare case report highlights the association of temporomandibular joint ankylosis with psoriasis and familial Mediterranean fever. This finding may provide insights into the complex interplay between these conditions.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.